Jennifer Lynne Fox - 23 Feb 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Ext Aff, GC, Corp Sec
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
23 Feb 2024
Net transactions value
-$627
Form type
4
Filing time
27 Feb 2024, 20:28:41 UTC
Previous filing
14 Nov 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $627 -229 -0.13% $2.74 178,564 23 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.